Shi Dong

556 total citations
28 papers, 388 citations indexed

About

Shi Dong is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Shi Dong has authored 28 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Shi Dong's work include Pancreatic and Hepatic Oncology Research (12 papers), Pancreatitis Pathology and Treatment (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Shi Dong is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Pancreatitis Pathology and Treatment (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Shi Dong collaborates with scholars based in China. Shi Dong's co-authors include Wence Zhou, Wenkai Jiang, Wence Zhou, Zhou Chen, Xin Li, Zhengfeng Wang, Wancheng Li, Wenkai Jiang, Xin Li and Shaofeng Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Shi Dong

26 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shi Dong China	12	207	120	65	63	58	28	388
Ken Tsuboi Japan	10	154 0.7×	94 0.8×	53 0.8×	54 0.9×	60 1.0×	28	404
Duchuang Wang China	7	198 1.0×	89 0.7×	73 1.1×	62 1.0×	30 0.5×	8	336
Yueguang Wu China	9	272 1.3×	118 1.0×	102 1.6×	71 1.1×	42 0.7×	17	435
Ni Chai China	7	259 1.3×	102 0.8×	95 1.5×	73 1.2×	51 0.9×	9	431
Bobak Parang United States	9	236 1.1×	117 1.0×	83 1.3×	96 1.5×	42 0.7×	15	518
Shengjie Dai China	12	206 1.0×	103 0.9×	105 1.6×	48 0.8×	44 0.8×	31	437
Kenta Saito Japan	8	123 0.6×	107 0.9×	42 0.6×	53 0.8×	49 0.8×	33	312
Bing Dai China	9	293 1.4×	152 1.3×	106 1.6×	83 1.3×	45 0.8×	15	557
Shinan Li South Korea	12	201 1.0×	73 0.6×	66 1.0×	78 1.2×	36 0.6×	16	369

Countries citing papers authored by Shi Dong

Since Specialization

Citations

This map shows the geographic impact of Shi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Dong more than expected).

Fields of papers citing papers by Shi Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Dong. The network helps show where Shi Dong may publish in the future.

Co-authorship network of co-authors of Shi Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Dong. A scholar is included among the top collaborators of Shi Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Dong. Shi Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Yongqing, et al.. (2025). Glucose Metabolism Reprogramming of Immune Cells in the Microenvironment of Pancreatic and Hepatobiliary Cancers. Journal of Gastroenterology and Hepatology. 40(2). 355–366.

Wang, Zhengfeng, Shi Dong, & Wence Zhou. (2024). Pancreatic stellate cells: Key players in pancreatic health and diseases (Review). Molecular Medicine Reports. 30(1). 12 indexed citations

Yi, Jianfeng, Zhenzhen Ye, Hao Xu, et al.. (2024). EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Phytomedicine. 135. 156137–156137. 13 indexed citations

Han, Fangfang, et al.. (2024). Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells.. PubMed. 37(2). 327–336.

Shi, Huaqing, Xin Li, Zhou Chen, et al.. (2023). Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis. Journal of Personalized Medicine. 13(3). 409–409. 7 indexed citations

Du, Yan, Shi Dong, Wenkai Jiang, et al.. (2023). Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer. International Journal of Molecular Sciences. 24(16). 12787–12787. 9 indexed citations

Li, Xin, et al.. (2023). Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 31(4). 505–514. 4 indexed citations

Qiao, Rui & Shi Dong. (2023). Consortium Chain Consensus Vulnerability and Chain Generation Mechanism. Computers, materials & continua/Computers, materials & continua (Print). 77(2). 2505–2527. 2 indexed citations

Shi, Huaqing, et al.. (2022). A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study. BMC Gastroenterology. 22(1). 279–279. 8 indexed citations

10.

Chen, Zhou, Shaofeng Zhang, Shi Dong, Hao Xu, & Wence Zhou. (2022). Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations. Frontiers in Immunology. 13. 844401–844401. 28 indexed citations

11.

Dong, Shi, Wancheng Li, Xin Li, et al.. (2022). Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression. Frontiers in Immunology. 13. 1038650–1038650. 17 indexed citations

12.

Zhou, Wence, Shi Dong, Zhou Chen, Xin Li, & Wenkai Jiang. (2022). New challenges for microRNAs in acute pancreatitis: progress and treatment. Journal of Translational Medicine. 20(1). 192–192. 22 indexed citations

13.

Chen, Zhou, et al.. (2022). Challenges and Opportunities Associated With Platelets in Pancreatic Cancer. Frontiers in Oncology. 12. 850485–850485. 9 indexed citations

14.

Dong, Shi, et al.. (2022). Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis. Frontiers in Nutrition. 9. 865102–865102. 13 indexed citations

15.

Xiao, Li, et al.. (2021). Epidemiology of periodontal disease in adolescents in mainland China, 1983–2020: a systematic review and meta-analysis. Annals of Palliative Medicine. 10(1). 45–60. 9 indexed citations

16.

Jiang, Wenkai, Xin Li, Shi Dong, & Wence Zhou. (2021). Betulinic acid in the treatment of tumour diseases: Application and research progress. Biomedicine & Pharmacotherapy. 142. 111990–111990. 97 indexed citations

17.

Dong, Shi, Xin Li, Wenkai Jiang, Zhou Chen, & Wence Zhou. (2021). Current understanding of ferroptosis in the progression and treatment of pancreatic cancer. Cancer Cell International. 21(1). 480–480. 9 indexed citations

18.

Dong, Shi, et al.. (2021). Guizhi-Fuling formula inhibits ovarian cancer progression by targeting STAT3 signaling network. 4(4). 30–30. 1 indexed citations

19.

Wang, Jin, et al.. (2018). Constituent and effects of polysaccharides isolated from Sophora moorcroftiana seeds on lifespan, reproduction, stress resistance, and antimicrobial capacity in Caenorhabditis elegans. Chinese Journal of Natural Medicines. 16(4). 252–260. 26 indexed citations

20.

Dong, Shi. (2002). Manipulation of plant fatty acid. Shengming kexue. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact